Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
TME PHARMA CEO MESSAGE
Berlin, Germany, September 16, 2026, 8.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for brain cancer and eye diseases, today publishes a…
Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program
The donation marks a new phase for TAP, with Royalty Pharma serving as the first and largest corporate donor under an updated model that invites direct donations to the program. TAP donations are deployed as venture capital investments in…
Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler
Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg. The product is a generic equivalent of QVAR…
Gland Pharma to acquire 100% stake in Gland Pharma USA
The Board of Directors of Gland Pharma has approved the acquisition of 100 per cent of the equity share capital of Gland Pharma USA Inc. a wholly-owned step-down subsidiary of the Company, from Gland Pharma International Pte. Ltd, a wholly-owned…
Aurobindo Pharma gets USFDA approval for generic inhalation aerosol for asthma patients
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol, a generic equivalent of Qvar Inhalation Aerosol marketed by Teva Branded…
BridgeBio Pharma (NASDAQ:BBIO) Trading Down 6.4% - Here's Why
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) were down 6.4% on Tuesday. The stock traded as low as $69.17 and last traded at $67.77. 911,774 shares were traded during mid-day trading, a decline of 68% from the average session…
Insider Buying: NewAmsterdam Pharma (NASDAQ:NAMS) CEO Acquires 10,000 Shares of Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CEO Michael Davidson acquired 10,000 shares of NewAmsterdam Pharma stock in a transaction on Monday, September 14th. The stock was purchased at an average cost of $22.65 per share…
Avalyn Pharma (NASDAQ:AVLN) Shares Gap Up - Should You Buy?
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report)'s share price gapped up prior to trading on Tuesday. The stock had previously closed at $33.57, but opened at $35.01. Avalyn Pharma shares last traded at $34.46, with a volume of 5,918 shares…
Tighter scrutiny of Hong Kong IPOs could slow deal flow, analysts say
Securities regulators in Hong Kong and mainland China are doubling down on efforts to raise the quality of Hong Kong initial public offerings (IPOs), which could slow the flow of new listings but would not reduce underlying demand, according to…
Show me the receipts!': Warren grills RFK Jr. aide on drug pricing deals
“Show me the receipts!” Warren said during her heated exchange with Klomp. “Why are you hiding these contracts?” The MFN deals, which promise to lower prescription drug prices in the United States to match those in other…
Lonza Group AG (LZAGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Lonza Group AG (LZAGY) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 10:45 AM EDT Philippe Deecke - Chief Financial Officer Thibault Boutherin - Morgan Stanley, Research Division Morgan Stanley, Research Division So…
Healthpeak Properties: Outpatient And Senior Portfolio Shows Proven Performance
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Wells Fargo upgraded Ulta Beauty (ULTA) to Equal Weight from…
Futures Drop As Yields, Oil Prices Keep Rising
Futures are lower - but well off session lows thanks to some well-time oil sell orders just before US traders walked in to work - as bond yields continue to make new highs, with both Nasdaq and Russell lagging the S&P which feels like more…
How AI is rewriting the rules for medicine and biotech in Mass.
Three health care leaders laid out how artificial intelligence is reshaping medical work, from the lab to the clinic, at a recent Axios Live event in Cambridge. Why it matters: Our speakers agreed AI in pharma and medicine means more than just a…
Receive a Daily briefing on Pharma Industry News
Get Started